Sarah Hamidi, M.D., FRCPC
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2017 | University of Montreal, Montreal, QC, CA, Medicinae Doctorem (M.D.) |
| 2013 | University of Montreal, Montreal, QC, CA, Pre-medical Year |
Postgraduate Training
| 2022-2024 | Advanced clinical and research fellowship, Oncologic Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2021-2022 | Chief Resident, Adult Endocrinology and Metabolism, The University of Montreal Hospital Center (CHUM), Montreal, QC |
| 2020-2022 | Clinical fellowship, Adult Endocrinology and Metabolism, University of Montreal, Montreal, QC |
| 2017-2020 | Clinical residency, Internal Medicine, University of Montreal, Montreal, QC |
Licenses & Certifications
| 2025 | Texas Medical License |
| 2022 | Board Certification in Adult Endocrinology and Metabolism by the Royal College of Physicians and Surgeons of Canada |
| 2020 | Board Certification in Internal Medicine by the Royal College of Physicians and Surgeons of Canada |
Honors & Awards
| 2025 | Travel Grant for the 2025 International Thyroid Congress, American Thyroid Association |
| 2025 | Cyrus Scholar Award for Outstanding Clinical Research, The University of Texas MD Anderson Cancer Center |
| 2024 | 2024 Outstanding Trainee Poster Award, American Thyroid Association |
| 2024 | Ridgeway Trainee Travel Grant, American Thyroid Association |
| 2023 | 2023 Women Advancing Thyroid Research Award, American Thyroid Association |
| 2023 | Ridgeway Trainee Travel Grant, American Thyroid Association |
| 2023 | First place at the 2023 Division of Internal Medicine Research Retreat, Clinical Research poster session, The University of Texas MD Anderson Cancer Center |
| 2022 | Dean's Honor List - Postgraduate Medical Education, University of Montreal |
| 2022 | The Department of Medicine's Trainee Excellence Award, The University of Montreal Hospital Center (CHUM) |
| 2018 | Internal Medicine Resident Excellence Award, Maisonneuve-Rosemont Hospital, Montreal, QC |
| 2017 | Dean's Honor List - M.D, University of Montreal |
| 2012 | Highest Honors and Jury's Praise at the French Baccalaureate, Stanislas College, Montreal, QC |
Professional Memberships
Selected Presentations & Talks
Formal Peers
- 2025. The Basics of Clinical research in Oncologic Endocrinology. Houston, Texas, US.
- 2025. Thyroid Cancer: An Overview. Puerto Rico, PR.
- 2024. Management of Anaplastic Thyroid Cancer in 2024. Houston, Texas, US.
- 2024. Current and Future Therapies for Advanced Thyroid Cancers. Houston, Texas, US.
Selected Publications
Peer-Reviewed Articles
- Salim HA, Msherghi A, Learned K, Zafereo M, Wang J, Dagher SA, Altintas Taslicay C, Dagher R, Alizada S, Hu MI, Cabanillas ME, Busaidy N, Hamidi S, Tawbi H, Li J, Ucisik FE, Wintermark M. Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis. Thyroid, 2025. e-Pub 2025. PMID: 40956665.
- Fournier I, Bandi AV, Hamidi S, Iyer P, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Waguespack SG, Basmaci UN, Williams MD, Mansour M, Monroe MG, Gross ND, Goepfert RP, Perrier ND, Banuchi V, Wang JR, Maniakas A, Zafereo ME. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head and Neck 48(1):237-245, 2025. e-Pub 2025. PMID: 40891104.
- Hawes EE, Banuchi VE, Maniakas A, Wang JR, Graham PH, Diersing JD, Busaidy NL, Cabanillas ME, Dadu R, Hamidi S, Iyer P, Waguespack SG, Ahmed S, Alizada S, Belcastro A, Alsharif R, Hu MI, Zafereo ME. Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques. Head Neck 48(2):E20-E24, 2025. e-Pub 2025. PMID: 40747656.
- Cabanillas, ME, Busaidy, NL, Gunn, GB, Iyer, PC, Ferrarotto, R, Gule-Monroe, MK, Maniakas, A, Williams, MD, Liu, S, Fellman, B, Spiotto, MT, Hamidi, S, Akhave, NS, Lee, A, Wang, RJ, De Sousa, LG, Marczyk, VR, Zafereo, M, Dadu, R. Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid 35(7):763-770, 2025. e-Pub 2025. PMID: 40609521.
- Hamidi S, Zafereo ME, Wang JR, Maniakas A, Busaidy NL, Dadu R, Iyer PC, Cabanillas ME. Circulating Tumor DNA as a Biomarker for Disease surveillance in Anaplastic Thyroid Cancer. JCO Precis Oncol 9(e2500067), 2025. e-Pub 2025. PMID: 40570261.
- Hamidi S, Maniakas A, Akhave NS, Banuchi VE, Busaidy NL, Dadu R, Ferrarotto R, Guise TA, Hofmann M, Hosseini S, Hu MI, Iyer PC, Mansour M, Marczyk VR, Roy-Chowdhuri S, Sherman SI, Sousa LG, Wang JR, Williams MD, Zafereo ME, Waguespack SG, Cabanillas ME. Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues. The Journal of Clinical Endocrinology & Metabolism, 2025. e-Pub 2025. PMID: 40568752.
- Cabanillas, ME, Akhave, NS, Banuchi, VE, Busaidy, NL, Dadu, R, Ferrarotto, R, Gunn, GB, Hamidi, S, Hofmann, M, Hosseini, SM, Iyer, PC, Lai, SY, Lee, A, Maniakas, A, Ning, M, Spiotto, MT, Wang, RJ, Williams, MD, Zafereo, M. Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer. Thyroid 35(5):462-470, 2025. e-Pub 2025. PMID: 40388579.
- Marczyk, VR, Fazeli, S, Dadu, R, Busaidy, NL, Iyer, PC, Hu, MI, Sherman, SI, Hamidi, S, Hosseini, SM, Williams, MD, Ahmed, S, Routbort, MJ, Luthra, R, Roy Chowdhuri, S, San Lucas, FA, Patel, KP, Hong, DS, Zafereo, M, Wang, RJ, Maniakas, A, Waguespack, SG, Cabanillas, ME. NTRK Fusion-Positive Thyroid Carcinoma. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 39983078.
- Hamidi S, Ning MS, Phan J, Zafereo ME, Gule-Monroe MK, Dadu R. Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy. JCEM Case Rep 3(2), 2025. e-Pub 2025. PMID: 39866918.
- Dudzinski, SO, Cabanillas, ME, Hamidi, S, Marczyk, VR, Busaidy, NL, Dadu, R, Welsh, J, Hu, MI, Gunn, GB, Wang, C, Waguespack, SG, Phan, J, Beckham, TH, Chang, JY, Sherman, SI, Reddy, JP, Ying, AK, O'Reilly, M, Chen, A, Lee, A, Gandhi, S, Liao, Z, Ludmir, EB, Nguyen, Q, Lin, SH, Zafereo, M, Ning, M. Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer. JNCCN Journal of the National Comprehensive Cancer Network 23(1), 2025. e-Pub 2025. PMID: 39662038.
- Hamidi, S, Yedururi, S, Hu, MI, Busaidy, NL, Sherman, SI, Jimenez, C, Grubbs, EG, Maniakas, A, Zafereo, M, Subbiah, V, Waguespack, SG. Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid 35(1):6-17, 2025. e-Pub 2025. PMID: 39630530.
- Hamidi S, Mahvash A, Hu MI. Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases. JCEM Case Rep 2(8), 2024. e-Pub 2024. PMID: 39076377.
- Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 34(3):336-346, 2024. e-Pub 2024. PMID: 38226606.
- Hamidi S, Boucher A, Lemieux B, Rondeau G, Lebœuf R, Ste-Marie L, Le XK, Mircescu H. Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects. J Endocr Soc 6(6), 2022. e-Pub 2022. PMID: 35475024.
- Hamidi S, Mottard S, Berthiaume MJ, Doyon J, Bégin MJ, Bondaz L. Brown tumor of the iliac crest initially misdiagnosed as a giant cell tumor of the bone. Endocrinol Diabetes Metab Case Rep, 2020. e-Pub 2020. PMID: 32478667.
Invited Articles
- Shariq OA, Waguespack SG, Hamidi S, Kensing BC, Hu MI, Skefos CM, Perrier ND. Approach to the Patient: Hereditary Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 110(9):2685-2697, 2025. e-Pub 2025. PMID: 40105880.
- Hamidi S, Maniakas A. Recent advances in anaplastic thyroid cancer management. Curr Opin Endocrinol Diabetes Obes 30(5):259-264, 2023. e-Pub 2023. PMID: 37410453.
Review Articles
- Hamidi, S, Maniakas, A, Cabanillas, ME. Advances in Anaplastic Thyroid Cancer Treatment. Endocrinology and Metabolism Clinics of North America 54(3):361-375, 2025. e-Pub 2025. PMID: 40716892.
- Hamidi S, Turner N, Ouni R, Rico R, Henderson YC, Puche M, Alekseev S, Colunga-Minutti JG, Zafereo ME, Lai SY, Kim ST, Cabanillas ME, Nurieva R. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy. Front Immunol 15, 2024. e-Pub 2024. PMID: 38868771.
- Hamidi S, Hu MI. RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Ann Endocrinol (Paris) 85(2):118-126, 2024. e-Pub 2024. PMID: 38342224.
- Keam, S, Turner, N, Grande Kugeratski, F, Rico, R, Colunga-Minutti, JG, Poojary, R, Alekseev, S, Patel, A, Li, YJ, Sheshadri, A, Loghin, ME, Woodman, K, Aaroe, AE, Hamidi, S, Iyer, PC, Palaskas, NL, Wang, Y, Nurieva, R. Toxicity in the era of immune checkpoint inhibitor therapy. Frontiers in immunology 15, 2024. e-Pub 2024. PMID: 39247203.
- Hamidi S, Hofmann M, Iyer PC, Cabanillas ME, Hu MI, Busaidy NL, Dadu R. Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front Endocrinol (Lausanne) 14, 2023. e-Pub 2023. PMID: 37435488.
Other Articles
- Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn G, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini S, Busaidy NL, Cabanillas ME Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol, 2024. PMID: 38990526.
- Hamza A Salim MD, Kim Learned MD, Mark Zafereo MD, Jennifer Wang MD, MBBCh AM, Samir A Dagher MD, Ceylan Altintas Taslicay MD, Qudah MBBS HA, Sahar Alizada MD, Mimi I Hu MD, Maria E Cabanillas MD, Naifa Busaidy MD, Sarah Hamidi MD, Hussein Tawbi MD, Rami W Eldaya MD, Jing Li MD, Max Wintermark MD Whole Brain Radiation Therapy for Brain Metastases due to Thyroid Cancer: A Systematic Review and Meta-analysis. Clinical Oncology.
Letters to the Editor
- Matrone A, Kroiss M, Gild ML, Hamidi S, Sayehli CM, Siddal R, Gambale C, Prete A, Hu MI, Robinson BG, Elisei R. Erectile Dysfunction in Patients Treated with Selpercatinib for RET-Altered Thyroid Cancer. Thyroid, 2024.
Patient Reviews
CV information above last modified February 12, 2026